{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024514","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.887803+00:00","generated_at":"2026-06-01T03:11:21.671049+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ainos reports 75-case clinical trial progress for Ainos Flora; next-gen device with NVIDIA CUDA targeting Q3/Q4","bullets":["Clinical trials for AI Nose-powered Ainos Flora achieved 75 meaningful case results, validating AI algorithm model.","Next-gen Ainos Flora will leverage NVIDIA CUDA for accelerated deep learning; design completion expected Q3, clinical trials Q4.","Second-generation device targets at-home testing for viral infections, expanding beyond bacterial/fungal/STI detection.","Board approved amended bylaws reducing stockholder meeting quorum to one-third and adding advance notice procedures.","STI testing market projected US$256B by 2028; POCT accounts for 31%, presenting opportunity for telehealth-friendly rapid testing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024514","json":"https://secwatch.observer/filing/0001493152-24-024514.json","markdown":"https://secwatch.observer/filing/0001493152-24-024514.md","text":"https://secwatch.observer/filing/0001493152-24-024514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224024514/0001493152-24-024514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224024514/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:11:21.671049+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}